Enzymatic Therapy
This article was originally published in The Tan Sheet
Executive Summary
Supplement manufacturer's Heartburn Free product will not feature the phrase "10 pills, 20 days, Heartburn Free" due to concerns raised by FDA, Green Bay, Wisc.-based firm states in a letter to the agency. Company maintains it had not yet used the structure/function claim on any product labeling when it received a courtesy letter from FDA. "Based on your objections," firm says to FDA, "you can be assured that we will not use [this phrase] on future product labels or in any labeling"...
You may also be interested in...
Israel's Gamida Cell Survives By Selling To Lender
Having finally secured US approval for Omisirge, Gamida was hoping to bag a strategic partner for the cell therapy. A year on, no suitable partner has been identified and the firm is delisting from the NASDAQ and going private.
EU Regulatory Assessors Get AI Boost In Reaching Scientific Decisions
The European Medicines Agency is training scientific staff working for the European medicines regulatory network in how to use a new AI-powered search engine that allows them to easily retrieve information on regulatory precedents.
EU Parliament Stricter Than Council On Medicines And Medical Devices Packaging
The EU Parliament's Environment, Public Health and Food Safety committee takes a compromise position with regards to the Packaging and Packaging Waste Directive. Medicines and medical devices should be exempt, but only until 2035, at which point the European Commission should check whether the development of materials and the recycling process have progressed, and may adjust this exemption accordingly.